Glycemic control, the unconsidered outcome in the treatment of nonalcoholic fatty liver disease

被引:1
作者
Garcia-Compean, Diego [1 ]
Orsi, Emanuela [2 ,3 ]
Nishida, Tsutomu [4 ]
Kumar, Ramesh [5 ]
机构
[1] Autonomous Univ Nuevo Leon, Univ Hosp, Dept Gastroenterol, Madero Gonzalitos Colonia Mitras CP 64700, Monterrey, NL, Mexico
[2] Univ Milan, Diabet Serv, Endocrinol & Metab Dis Unit, IRCCS Ca Granda Osped Maggiore Policlin Fdn, Milan, Italy
[3] Univ Milan, Dept Clin Sci, Milan, Italy
[4] Toyonaka City Hosp, Dept Gastroenterol, 4-14-1 Shibahara, Toyonaka, Osaka 5608565, Japan
[5] All India Inst Med Sci, Dept Gastroenterol, OPD Block,Phulwari Sharif, Patna 801507, Bihar, India
关键词
Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Glycemic control; Diabetes Mellitus; Liver fibrosis; TYPE-2; DIABETES-MELLITUS;
D O I
10.1016/j.aohep.2021.100648
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页数:2
相关论文
共 15 条
[1]   Glycemic Control Predicts Severity of Hepatocyte Ballooning and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease [J].
Alexopoulos, Anastasia-Stefania ;
Crowley, Matthew J. ;
Wang, Ying ;
Moylan, Cynthia A. ;
Guy, Cynthia D. ;
Henao, Ricardo ;
Piercy, Dawn L. ;
Seymour, Keri A. ;
Sudan, Ranjan ;
Portenier, Dana D. ;
Diehl, Anna Mae ;
Coviello, Andrea D. ;
Abdelmalek, Manal F. .
HEPATOLOGY, 2021, 74 (03) :1220-1233
[2]   Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study [J].
Armstrong, Matthew James ;
Gaunt, Piers ;
Aithal, Guruprasad P. ;
Barton, Darren ;
Hull, Diana ;
Parker, Richard ;
Hazlehurst, Jonathan M. ;
Guo, Kathy ;
Abouda, George ;
Aldersley, Mark A. ;
Stocken, Deborah ;
Gough, Stephen C. ;
Tomlinson, Jeremy W. ;
Brown, Rachel M. ;
Huebscher, Stefan G. ;
Newsome, Philip N. .
LANCET, 2016, 387 (10019) :679-690
[3]  
EASL, 2016, OBESITY FACTS, V9, P65, DOI [10.1007/s00125-016-3902-y, 10.1159/000443344, 10.1016/j.jhep.2015.11.004]
[4]   The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals [J].
Fukuda, Takuya ;
Hamaguchi, Masahide ;
Kojima, Takao ;
Hashimoto, Yoshitaka ;
Ohbora, Akihiro ;
Kato, Takahiro ;
Nakamura, Naoto ;
Fukui, Michiaki .
LIVER INTERNATIONAL, 2016, 36 (02) :275-283
[5]   Histological Course of Nonalcoholic Fatty Liver Disease in Japanese Patients - Tight glycemic control, rather than weight reduction, ameliorates liver fibrosis [J].
Hamaguchi, Erika ;
Takamura, Toshinari ;
Sakurai, Masaru ;
Mizukoshi, Eishiro ;
Zen, Yoh ;
Takeshita, Yumie ;
Kurita, Seiichiro ;
Arai, Kuniaki ;
Yamashita, Tatsuya ;
Sasaki, Motoko ;
Nakanuma, Yasuni ;
Kaneko, Shuichi .
DIABETES CARE, 2010, 33 (02) :284-286
[6]   Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients [J].
Nakahara, Takashi ;
Hyogo, Hideyuki ;
Yoneda, Masato ;
Sumida, Yoshio ;
Eguchi, Yuichiro ;
Fujii, Hideki ;
Ono, Masafumi ;
Kawaguchi, Takumi ;
Imajo, Kento ;
Aikata, Hiroshi ;
Tanaka, Saiyu ;
Kanemasa, Kazuyuki ;
Fujimoto, Kazuma ;
Anzai, Keizo ;
Saibara, Toshiji ;
Sata, Michio ;
Nakajima, Atushi ;
Itoh, Yoshito ;
Chayama, Kazuaki ;
Okanoue, Takeshi .
JOURNAL OF GASTROENTEROLOGY, 2014, 49 (11) :1477-1484
[7]   A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis [J].
Newsome, Philip N. ;
Buchholtz, Kristine ;
Cusi, Kenneth ;
Linder, Martin ;
Okanoue, Takeshi ;
Ratziu, Vlad ;
Sanyal, Arun J. ;
Sejling, Anne-Sophie ;
Harrison, Stephen A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (12) :1113-1124
[8]   Beyond HbA1c and Glucose: the Role of Nontraditional Glycemic Markers in Diabetes Diagnosis, Prognosis, and Management [J].
Parrinello, Christina M. ;
Selvin, Elizabeth .
CURRENT DIABETES REPORTS, 2014, 14 (11)
[9]   Pathogenesis of Nonalcoholic Steatohepatitis: An Overview [J].
Parthasarathy, Gopanandan ;
Revelo, Xavier ;
Malhi, Harmeet .
HEPATOLOGY COMMUNICATIONS, 2020, 4 (04) :478-492
[10]   Nonalcoholic Fatty Liver Disease and Diabetes: An Epidemiological Perspective [J].
Rhee, Eun-Jung .
ENDOCRINOLOGY AND METABOLISM, 2019, 34 (03) :226-233